Corcept Therapeutics Inc(CORT)
20.30
Change: -0.71 (▼ -3.51%)
As of Tue 12/20/2022 10:09 AM% Of Value
Growth
Value Per Share
:
:
:
323.73
3.42
6.6100 (as of 19/12/2022)
Fundamentals Data
| Open | 20.10 | Dividend | 101 |
| Close Price | 20.30 | DivYield | 0 % |
| High | 20.8 | Growth | 12.1 M |
| Low | 20.1 | Growth% | 3.42 |
| P/e | 18.256 | Volume | 1.0 M |
| P/b | 0.01 | Market Capital | 2.3 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 25.80 (as of 20/12/2022) | 50 Days Moving Average Percentage | -27.848364717542 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 159.2 M | 251.2 M | 306.4 M | 353.8 M | 365.9 M |
| Cap Spending | -419,000.0 | -298,000.0 | -1.0 M | -1.2 M | -469,000.0 |
| Operating Expenses | 102.7 M | 156.5 M | 189.3 M | 220.0 M | 236.2 M |
| Operating Cash Flow | 52.8 M | 89.4 M | 111.6 M | 128.2 M | 124.4 M |
| Free Cash Flow | 60.5 M | 115.3 M | 135.0 M | 150.7 M | 167.4 M |
| Free Cash Flow Per Share | 0.533 | 1 | 1.181 | 1.306 | 1.448 |
| Total liabilities | 0.0 | 0.0 | 3.4 M | 2.5 M | 526,000.0 |
| Total cash | 31.0 M | 41.6 M | 31.2 M | 76.1 M | 77.6 M |
| ROE% | 1.314 | 0.303 | 0.292 | 0.226 | 0.231 |
| Outstanding Shares | 114.8 M | 114.7 M | 114.5 M | 117.3 M | 105.9 M |
| P/E | 13.509 | 18.256 | 16.171 | 29.463 | 19.128 |
| P/S | 10.956 | 5.479 | 4.969 | 8.826 | 5.88 |
| Revenue USD | 159.2 M | 251.2 M | 306.4 M | 353.8 M | 365.9 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|